FDA approves Regeneron's Eylea HD for retinal vein occlusion, adding extended dosing options and greater flexibility across ...
Regeneron's EYLEA HD injection 8 mg approved by FDA for the treatment of macular edema following RVO
The US Food and Drug Administration (FDA) has approved aflibercept injection 8 mg (EYLEA HD) from Regeneron Pharmaceuticals ...
Once upon a time, dry eye disease was simple.Like a desert, an eye with dry eye disease (DED) simply had too little water to ...
First and only FDA-approved treatment for RVO indicated for up to every 8-week dosing after an initial monthly dosing period Monthly dosing ...
Groundbreaking study finds way to ‘reboot’ eye and restore impaired vision - Findings may lead to new treatment for ‘lazy eye ...
Regeneron (REGN) announced that the FDA has approved Eylea HD Injection 8 mg for the treatment of patients with macular edema following retinal ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback